We have provided compelling evidence for the anti-AD activities of RSSW, which included the attenuation of memory impairments, inhibition of tau hyperphosphorylation, and reduction of β-amyloid plaque deposition in SAMP8 mice. Here, MAPT is linked to Alzheimer disease.